Editorial: Women in gastrointestinal and hepatic pharmacology 2022

Eleonora Lai; Jessica Williams; Raquel Abalo; Daniela Gabbia

doi:10.3389/fphar.2023.1359135

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

Front Pharmacol. 2024 Jan 8:14:1359135. doi: 10.3389/fphar.2023.1359135. eCollection 2023.

Authors

Eleonora Lai¹, Jessica Williams², Raquel Abalo^{3

4

5

6

7}, Daniela Gabbia⁸

Affiliations

¹ Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
² Department of Pharmacology and Toxicology, University of Kansas Medical Center, Kansas City, KS, United States.
³ Área de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos (URJC), Alcorcón, Spain.
⁴ Unidad Asociada R+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁵ High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut-URJC). URJC, Alcorcón, Spain.
⁶ Grupo de Trabajo de Ciencias Básicas en Dolor y Analgesia de la Sociedad Española del Dolor (SED), Madrid, Spain.
⁷ Grupo de Trabajo de Cannabinoides de la SED, Madrid, Spain.
⁸ Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

No abstract available

Keywords: gastroenterology; hepatology; pharmacology; women in academia; women in science.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. RA research is supported by Ministerio de Ciencia, Innovación y Universidades (PID2019-111510RB-I00), Universidad Rey Juan Carlos and Banco de Santander (Call COVID-19, 2020) and Asociación Española de Gastroenterología (AEG, Call 2021).